Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on May 1, 2024. The transactions were executed in the open market with prices ranging from $109.70 to $113.40 per share, resulting in a total market value of approximately $1.66 million. Following these transactions, Afeyan directly holds 2,026,931 shares of Moderna. Additionally, indirect holdings through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc. amount to 9,666,038 shares.